FDA approves Kato Pharma`s IND to conduct human studies using Resolv ER
18 Feb 2022 //
PHARMABIZ
Kato Wins FDA Approval for Human Studies of Drug for Retinal Disorders
16 Feb 2022 //
PRNEWSWIRE
18 Feb 2022 //
PHARMABIZ
16 Feb 2022 //
PRNEWSWIRE